GH Amplifier

The classic growth hormone research duo. Ipamorelin and CJC-1295 activate complementary receptors — GHSR and GHRHR — to produce synergistic GH pulse amplification that neither compound achieves alone.

Ipamorelin is a selective growth hormone secretagogue receptor (GHSR) agonist that triggers discrete GH pulses with minimal cortisol or prolactin co-secretion. CJC-1295 is a stabilized GHRH(1-29) analog that acts on the pituitary GHRH receptor (GHRHR), increasing both the frequency and amplitude of natural GH pulses. The dual-receptor model is a well-established pharmacological principle in GH research: GHRP agonists (Ipamorelin) and GHRH analogs (CJC-1295) converge on distinct intracellular cascades — Gq/PKC and Gs/cAMP respectively — within the same somatotroph cell. This convergence produces a multiplicative rather than additive increase in GH secretion.

Key Research Areas

• Dual-receptor GH axis activation research
• GHSR and GHRHR convergence studies
• GH pulse amplitude and frequency investigation
• Somatotroph intracellular signaling cascade models

Research Applications

• Growth hormone secretagogue receptor pharmacology
• GHRH analog pituitary signaling research
• GH pulse kinetics and somatotroph biology studies
• Dual-receptor convergence and GH output modeling

Bundle Savings

This research stack includes a 10% discount compared to purchasing compounds individually. All components are third-party tested with Certificates of Analysis available for each batch.

For research use only. Not for human or animal consumption.